Proof-of-concept Studies for siRNA-mediated Gene Silencing for Coagulation Factors in Rat and Rabbit

Zhu Chen(North China Electric Power University), Marija Tadin‐Strapps, Anil Thankappan(United States Military Academy), Karen Leander(United States Military Academy), Dietmar Seiffert(Bristol-Myers Squibb (United States)), Seth Clark(Merck & Co., Inc., Rahway, NJ, USA (United States)), Traci Lifsted(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jyoti Disa(Merck & Co., Inc., Rahway, NJ, USA (United States)), Marian E. Gindy(Merck & Co., Inc., Rahway, NJ, USA (United States)), Laura Sepp‐Lorenzino(Intellia Therapeutics (United States)), Nina Jochnowitz(Merck & Co., Inc., Rahway, NJ, USA (United States)), Peter Szczerba(United States Military Academy), Christine Jachec(Merck & Co., Inc., Rahway, NJ, USA (United States)), Walter Strapps, Lizbeth Hoos(AIL Research (United States)), Marty DiPietro(Merck & Co., Inc., Rahway, NJ, USA (United States)), Weizhen Wu(Third Affiliated Hospital of Guangzhou Medical University), Bin Luo(Anhui University), Yuchen Zhou(Merck & Co., Inc., Rahway, NJ, USA (United States)), Yiming Xu(Tsinghua University), Tian‐Quan Cai(Merck & Co., Inc., Rahway, NJ, USA (United States)), Jillian DiMuzio(United States Military Academy), Bruce Ng(United States Military Academy), Laura S. Lubbers(United States Military Academy)
Molecular Therapy — Nucleic Acids
January 1, 2015
Cited by 23


Related Papers